The Association Between Intravenous Haloperidol and Torsades de Pointes
- 1 November 1995
- journal article
- case report
- Published by Elsevier in Psychosomatics
- Vol. 36 (6) , 541-549
- https://doi.org/10.1016/s0033-3182(95)71609-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The long QT syndromes: A critical review, new clinical observations and a unifying hypothesisProgress in Cardiovascular Diseases, 1988
- Torsades de pointes associated with drugs and toxins: Recognition and managementAmerican Heart Journal, 1987
- Haloperidol and Torsades de PointesAnnals of Internal Medicine, 1985
- Thioridazine-Induced Torsade de PointesPublished by American Medical Association (AMA) ,1983
- Q-T prolongation and torsades de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotilineThe American Journal of Cardiology, 1983
- Doxepin Induced Torsade De PointesPacing and Clinical Electrophysiology, 1982
- Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.Circulation, 1981
- "Les Torsades de Pointes": An Unusual Ventricular ArrhythmiaAnnals of Internal Medicine, 1980
- Torsade De Pointes, an atypical ventricular tachycardia.Heart, 1976
- Thioridazine (Mellaril®)-induced Ventricular Tachycardia Controlled with an Artificial PacemakerAnnals of Internal Medicine, 1966